Agonist-independent alteration in beta-adrenoceptor-G-protein-adenylate cyclase system in an equine model of recurrent airway obstruction.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research observed beta-adrenergic mechanisms in horses with recurrent airway obstruction (RAO) to test the theory that dysfunction of beta-adrenergic receptors stems from more than just surface receptor density. Instead, the dysfunction may include a defect in the intracellular signaling components. The findings suggested that RAO resulted in a reduction of beta-adrenergic receptors, which also decreased the efficiency of receptor coupling to G(S)-protein. As a result, the activation of adenylate cyclase by isoproterenol was significantly reduced in the lungs and bronchial membranes of animals with RAO. The study concluded that the entire signaling system is impaired in stable asthma, making the equine RAO model a potentially suitable representation of chronic asthma in humans.
Study Objective and Model
- The research aimed to study the dysfunction in beta-adrenergic receptors in horses suffering from recurrent airway obstruction (RAO), a condition similar to chronic asthma in humans. The study hypothesized that this dysfunction was not just limited to receptor density, but also included defects in intracellular signaling mechanisms.
Method and Findings
- The researchers compared various tissues in healthy and RAO-afflicted horses. They observed a significant reduction in the density of beta-adrenergic receptors in the afflicted horses’ lung and bronchial tissues, compared to the healthy ones.
- Alongside this receptor reduction, there was also poor coupling efficiency between the receptor and the G(S)-protein, a protein involved in biochemical signaling.
- Furthermore, the researchers noticed a significant reduction in the activation of adenylate cyclase (an important enzyme in the signal transduction pathway) in the lung and bronchial tissues in horses with RAO. This reduced activation was triggered by isoproterenol, a medication acting on beta-adrenergic receptors.
- Notably, no difference was observed in the receptor density or GS-protein coupling in the trachea between the control and RAO-afflicted group.
Conclusion and Implications
- Based on the findings, the researchers concluded that in cases of stable asthma, the entire beta-adrenergic receptor-G(S)-protein-adenylate cyclase system is affected.
- This conclusion suggests the dysfunction is not restricted to just beta-adrenergic receptor density but extends to the associated signaling connections, causing a comprehensive disruption.
- As the lung condition of these horses closely resembled chronic asthma in humans, they suggested that this animal model could be a suitable representation for further studying the disease.
Cite This Article
Publication
Researcher Affiliations
- Institute of Pharmacology, Pharmacy and Toxicology, Leipzig University, Germany. gabraham@rz.uni-leipzig.de
MeSH Terms
- Adenylyl Cyclases / metabolism
- Adrenergic beta-Agonists / pharmacology
- Adrenergic beta-Antagonists / pharmacology
- Airway Obstruction / metabolism
- Airway Obstruction / physiopathology
- Animals
- Binding Sites
- Bronchi / drug effects
- Bronchi / metabolism
- Bronchi / physiopathology
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Horses
- Iodine Radioisotopes
- Iodocyanopindolol / pharmacology
- Isoproterenol / pharmacology
- Lung / drug effects
- Lung / metabolism
- Lung / physiopathology
- Muscle, Smooth / drug effects
- Muscle, Smooth / metabolism
- Receptors, Adrenergic, beta / physiology
- Recurrence
- Signal Transduction / drug effects
- Trachea / drug effects
- Trachea / metabolism
- Trachea / physiopathology
Citations
This article has been cited 1 times.- Shibeshi W, Abraham G, Kneuer C, Ellenberger C, Seeger J, Schoon HA, Ungemach FR. Isolation and culture of primary equine tracheal epithelial cells. In Vitro Cell Dev Biol Anim 2008 Jul-Aug;44(7):179-84.